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introduction
sarcopenia, the age-associated loss of muscle mass and
function, is associated with increased risks of mortality,
functional impairment and physical disability (1-4) and
accounts for substantial healthcare expenditure (5). sarcopenia
is common in older people with prevalence estimates from 5-
13% among 60-70 year olds, rising to 11-50% for those over 80
years (6). this variability in prevalence is related to a range of
measurement methods and cut-points used to define sarcopenia
(6), since an operational definition has not yet been adopted (7).
sarcopenia has a multifactorial etiology which is not fully
understood. obesity is a strong determinant of sarcopenia and
risk is increased by physical inactivity, current smoking, and
low protein intake (1, 8, 9). Additionally, low levels of energy
intake, vitamin D, antioxidants and omega-3 polyunsaturated
fatty acids may be important in the development of sarcopenia
(10). Recent evidence also suggests cardiovascular and
inflammatory biomarkers are important contributors to
sarcopenia progression (11). in addition, there is a suggestion
from clinical studies that endothelial dysfunction may also
contribute to sarcopenia (12) but less has been studied in the
general population.
it is important to establish the contributions of a wide variety
of potential low muscle mass determinants as well as potential
mechanisms linking sarcopenia to mortality to inform the
development of specific prevention and intervention strategies
in older people. the aim of this study was to explore the
associations between an extensive range of lifestyle and dietary
risk factors associated with low muscle mass and to explore the
role of novel cardiovascular risk markers (including metabolic
risk factors, markers of inflammation, endothelial dysfunction
and coagulation) in a population of older men. We used two
separate assessments of muscle mass, based on arm
measurements and bioelectrical impedance. 
methods
Participants and study design
the British Regional Heart study is a prospective study
investigating cardiovascular disease, in a socioeconomically
and geographically representative sample of 7735 British men,
from 24 towns in Great Britain (13). this cohort was first
examined in 1978-80. twenty years later, in 1998-2000, 4252
men (77% of survivors), then aged 60-79 years, attended a
physical examination, provided a fasting blood sample,
completed a general questionnaire and a food frequency
questionnaire (14).  Men provided written informed consent, in
accordance with the Declaration of Helsinki. ethical approval
was obtained from relevant local research ethics committees. 
Anthropometric measurements
Height, weight, waist circumference, fat-free mass,
midupper arm circumference and triceps skinfold thickness
were measured at re-examination in 1998-2000, as described
previously (3). two muscle mass markers were used: midarm
muscle circumference (MAMc) and fat-free mass index
(FFMi). MAMc (cm) was calculated as: midupper arm
circumference (cm) - 0.3142 x triceps skinfold thickness (mm)
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(15). Midupper arm circumference was measured once using an
arm pendant. triceps skinfold thickness was based on the
average of two measurements. Fat-free mass was determined by
bioelectrical impedance analysis (BiA) using a Bodystat 500
(Bodystat Ltd, Douglas, uk) and the Deurenberg et al equation
(16). Fat-free mass was normalized for height by dividing by
height (m2) to give FFMi (kg/m2) (17). A standard statistical
approach was used to define low muscle mass (participants
below the first quartile of the distribution of MAMc or FFMi)
since no consensus definition of sarcopenia has yet been
adopted (7). However, MAMc correlates strongly with more
accurate dual-energy X-ray absorptiometry measures of lean
mass (18). in addition, the european Working Group on
sarcopenia has approved BiA measures as a portable
alternative to dual-energy X-ray absorptiometry (7). 
Dietary assessment
Dietary intake data were obtained using a food frequency
questionnaire; development and validation have been described
(19-21). Participants reported usual frequency of consumption
of 86 food and drink types. nutrient intakes were derived using
a validated computer program to calculate total nutrient
composition of foods consumed (22). in addition, participants
were asked to indicate how often they consumed fresh fruit and
vegetables – rarely/never, monthly, or 1, 2, 3, 4, 5, 6, or 7 days
per week. Daily consumption was classified as 7 days per week.
the multivariate nutrient density model was used to adjust
macronutrients for energy intake; carbohydrates, fats and
protein were expressed as percentages of energy (% kcal) and
energy intake was added to the logistic regression models for
all dietary variables (23). Plasma vitamin c and e were also
measured using high-performance liquid chromatography (22).
Cardiovascular disease risk factors
cigarette smoking, physical activity, alcohol intake and
social class were self-reported via questionnaire and blood
lipids and blood pressure were measured at the physical
examination as described elsewhere (3, 13, 24). Men were
classified into four smoking groups (never; long-term ex; recent
ex; current). current physical activity was classified in six
groups based on exercise frequency and intensity (inactive;
occasional; light; moderate; moderately vigorous; vigorous).
Alcohol intake was classified into five groups based on the
number and frequency of beverages consumed (none;
occasional; light; moderate; heavy). social class was split into
three groups (manual; non-manual; armed forces) based on the
longest held occupation using the Registrar General’s
occupational classification.  Forced expiratory volume in 1
second (FeV1) measured lung function and was height-
standardised to the mean height in this study (1.72m). 
the homeostasis model assessment was calculated to
estimate insulin resistance (HoMA-iR) (25). Metabolic
syndrome was classified according to the national cholesterol
education Program definition (26); ≥3 metabolic risk factors as
follows: 1) central obesity: waist circumference >102 cm; 2)
Fasting plasma glucose >6.1mmol/L; 3) serum triglyceride
>1.7 mmol/L; 4) serum high density lipoprotein (HDL)
cholesterol <1.04 mmol/L; and 5) Hypertension: blood pressure
>130/85mmHg or using blood pressure medication. Plasma
concentrations of c-reactive protein (cRP), tissue plasminogen
activator (t-PA) antigen, D-dimer, von Willebrand factor
(vWF), fibrinogen, interleukin 6 (iL-6) and homocysteine were
measured as described previously (22, 27, 28).
Morbidity
Participant questionnaires provided self-reported data on
doctor diagnosis of heart attack, angina, stroke, diabetes, heart
failure and cancer. Prevalent cardiovascular disease (cVD) was
defined as heart attack, angina or stroke diagnosis, and
prevalent coronary heart disease (cHD) as heart attack or
angina diagnosis. Participants were asked to rate their present
state of health as excellent, good, fair or poor and if they had
any long-standing illness or disability. Mobility limitation was
determined by whether participants stated they had difficulty
either going up/down stairs or walking for a quarter of a mile
on a level surface (17).
Statistical methods
of the 4252 men attending the physical examination, 4204
had MAMc data and 4114 had FFMi data for analysis.
Descriptive characteristics of participants were presented by
quartiles of the distribution of MAMc and FFMi. Distributions
of cRP, D-dimer, HoMA-iR, homocysteine and iL-6 were
highly skewed and log-transformed. tests for trend were
performed fitting MAMc/FFMi continuously using regression
analyses, adjusting for age and body mass index (BMi) fitted as
continuous variables. Additionally, we tested for an interaction
between sarcopenia and obesity, each fitted as binary variables,
with obesity defined using an established cut-point (≥30 kg/m2)
(29). However no evidence of interaction was found for any
risk factors.
Multiple logistic regression was performed to obtain odds
ratios for associations between risk factors and low muscle
mass (the lowest quartile of MAMc/FFMi). continuous
dietary, metabolic and inflammatory risk factors were divided
into quartiles and odds ratios for low muscle mass are presented
for the highest versus the lowest quartile. Models were adjusted
for potential confounders, associated with low muscle mass, in
a sequential manor, including age (model 1), BMi and lifestyle
characteristics (model 2) and morbidity variables (model 3).  in
addition, energy intake was included in the models for all
dietary variables assessed by the food frequency questionnaire.
Age, BMi, FeV1 and energy intake were fitted as continuous
variables. smoking, physical activity, alcohol, social class,
cVD, diabetes, cancer and poor/fair health were fitted as
categorical variables. statistical analyses were performed using
stata 12.0 (stata corp, college station, tX). 
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results
the study sample had a mean age of 68.7 years (range: 60-
79), MAMc of 26.5 cm (sD: 2.3), FFMi of 17.3 kg/m2 (sD:
2.2) and BMi of 26.9 kg/m2 (sD: 3.7). MAMc and FFMi were
moderately correlated (r = 0.41, p<0.001). Participant
characteristics by MAMc quartiles are in table 1. MAMc was
inversely associated with age and positively associated with
BMi. After adjustment for age and BMi, MAMc was inversely
associated with smoking, heavy drinking, physical inactivity
and manual working class. energy, fiber, vitamin c, iron, daily
fruit and vegetable consumption and plasma vitamin e showed
significant positive linear trends with MAMc, but percent
energy from fat showed a significant inverse linear trend.
HoMA-iR and high glucose were the only metabolic variables
significantly associated with MAMc. evidence of a significant
inverse linear trend was found between MAMc and
homocysteine, cRP, t-PA, D-dimer, vWF, fibrinogen and iL-6,
after age and BMi adjustment.
similar, less consistent, linear trends were observed between
variables and FFMi quartiles, compared to MAMc quartiles
(table 2). Morbidity prevalence of participants by quartiles of
MAMc and FFMi appear in supplementary table 1 and 2
respectively. MAMc showed a significant positive association
with FeV1 and a significant inverse association with cVD,
cHD, heart failure, poor/fair self-rated health, long-standing
illness/disability and mobility limitation, after age and BMi
adjustment (p<0.01). in comparison, FFMi showed similar
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table 1
Participant characteristics by MAMc Quartiles 
mamc Quartiles (cm) 
≤24.95 24.95-26.45 26.45-27.97 ≥27.97 p-value for trend p-value for trend 
n=1051 n=1051 n=1051 n=1051 (age adjusted) (age & Bmi adjusted)
Socio-demographic/Lifestyle variables
Age (years) 70.2 ± 5.7 69.3 ± 5.5 68.4 ± 5.3 67.0 ± 5.0 <0.001a <0.001b
obesity (BMi ≥ 30 kg/m2) (%) 2.9 7.7 17.1 39.4 <0.001 n/a
current smokers (%) 17.9 14.1 9.8 9.4 <0.001 <0.001
Heavy drinkers (%) 3.8 3.0 2.5 2.4 0.29 0.03
Physically inactive (%) 15.1 9.4 10.2 10.8 0.09 <0.001
Manual workers (%) 53.2 49.1 50.1 50.8 0.30 <0.001
Dietary variables 
energy intake (kcal) 2125.7 ± 524.4 2125.6 ± 528.6 2100.4 ± 524.3 2103.0 ± 542.4 0.41 0.02
carbohydrates (% kcal) 53.1 ± 6.9 52.8 ± 6.9 52.5 ± 6.9 52.1 ± 7.1 <0.001 0.06
Protein (% kcal) 15.4 ± 2.3 15.7 ± 2.4 15.8 ± 2.3 15.8 ± 2.3 0.001 0.10
Fat (% kcal) 30.5 ± 6.1 30.1 ± 6.2 29.9 ± 6.3 30.0 ± 6.3 0.99 0.04
Fiber (g/day) 25.6 ± 9.0 26.1 ± 8.6 25.8 ± 8.5 26.2 ± 8.9 0.25 <0.001
Vitamin c  (mg/day) 79.2 ± 36.3 82.8 ± 36.3 83.7 ± 36.2 87.1 ± 39.5 <0.001 0.001
Vitamin e (mg/day) 8.4 ± 4.8 8.4 ± 4.8 8.5 ± 4.7 8.5 ± 5.0 0.31 0.08
iron (mg/day) 14.0 ± 5.1 14.4 ± 5.5 14.1 ± 5.0 14.2 ± 5.3 0.26 <0.001
Daily fruit intake (%) 40.5 42.8 44.7 44.2 0.002 0.01
Daily vegetable intake (%) 30.9 32.9 33.2 35.1 0.002 <0.001
Plasma vitamin c (µmol/L) 30.1 ± 28.9 30.1 ± 28.6 31.0 ± 27.9 29.5 ± 23.5 0.39 0.26
Plasma vitamin e (µmol/L) 32.1 ± 11.4 33.8 ± 12.0 34.3 ± 11.8 33.8 ± 12.2 0.001 0.01
Metabolic variables
HoMA-iRc 1.9 (1.1-2.7) 2.1 (1.4-3.0)  2.3 (1.5-3.2)  2.7 (1.7-4.0)  <0.001 0.002
central obesity (%) 9.0 19.5 31.9 54.7 <0.001 n/a
Hypertension (%) 53.8 56.1 62.9 63.4 <0.001 0.32
High triglycerides (%) 33.4 42.4 46.8 56.9 <0.001 0.08
Low HDL (%) 15.2 18.7 21.3 27.9 <0.001 0.77
High glucose (%) 25.0 24.2 23.5 27.3 0.001 0.006
Metabolic syndrome (%) 13.5 20.8 29.7 42.9 <0.001 0.57
Inflammatory/biological markers
cRP (mg/L)c 1.8 (0.8-3.8)  1.7 (0.8-3.5)  1.7 (0.8-3.3) 1.7 (0.9-3.4) 0.09 <0.001
t-PA (ng/mL) 10.5 ± 4.6 10.9 ± 4.4 11.2 ± 4.5 11.6 ± 4.2 <0.001 0.01
D-dimer (ng/mL)c 94.2 (52.0-145.0) 88.4 (50.0-134.0) 83.5 (47.0-128.0) 72.8 (46.0-105.0) 0.002 <0.001
vWF (iu/dL) 147.3 ± 48.6 141.2 ± 46.1 136.6 ± 44.1 134.0 ± 44.4 <0.001 <0.001
Fibrinogen (g/L) 3.4 ± 0.8 3.3 ± 0.8 3.3 ± 0.7 3.2 ± 0.7 <0.001 <0.001
iL-6 (pg/mL)c 2.6 (1.6-3.8) 2.5 (1.6-3.4) 2.6 (1.5-3.4) 2.4 (1.6-3.3) 0.53 <0.001
Homocysteine (µmol/L)c 13.2 (10.4-16.0) 12.7 (10.3-14.9) 12.6 (10.3-14.7) 12.2 (10.0-14.2) 0.002 <0.001
Values presented as mean ± sD unless otherwise stated. BMi, body mass index; cRP, c-reactive protein; HDL, high density lipoprotein; HoMA-iR, homeostasis model assessment of
insulin resistance; iL-6, interleukin 6; MAMc, midarm muscle circumference; t-PA, tissue plasminogen activator; vWF, von Willebrand factor. a. unadjusted; b. Adjusted for BMi only;
c. Log-transformed-geometric mean (interquartile range) presented.
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patterns of association.
Multiple logistic regression analyses of risk factors and low
MAMc or FFMi appear in table 3. in the fully adjusted model,
physical inactivity and manual work (but not current smoking
or heavy drinking) were significantly associated with the odds
of low MAMc.  Men in the highest quartile (compared to the
lowest) of percent energy from protein, vitamin c, plasma
vitamin e, and daily fruit consumers, were at significantly
decreased odds of low MAMc, adjusting for age. However,
after adjusting for BMi, lifestyle and morbidity variables, these
associations were markedly attenuated and became non-
significant. Men with high energy intake and high percentage
energy from carbohydrates showed lower odds of low MAMc
even after adjustment.  By contrast, those with high percentage
energy from fat showed higher odds of low MAMc. High
HoMA-iR and blood glucose were associated with increased
odds of low MAMc after full adjustment. no independent
association was seen with other metabolic risk factors. HoMA-
iR was strongly correlated with obesity (r = 0.45, p<0.001),
which explains why the direction of association changed after
BMi adjustment. High levels of cRP, vWF and fibrinogen were
associated with increased odds of low MAMc after adjustment
for BMi, lifestyle and morbidity variables. D-dimer, t-PA, iL-6
and homocysteine were not significantly associated with low
MAMc. 
in comparison to MAMc analyses, consistent significant
associations were also observed between being in the lowest
FFMi quartile and physical inactivity, percent energy from
carbohydrates, HoMA-iR, cRP, vWF and fibrinogen in the
final model (table 3). in addition, plasma vitamin c, central
table 2
Participant characteristics by FFMi Quartiles  
ffmi Quartiles (kg/m2)
≤15.96 15.96-17.09 17.09-18.36 ≥18.36 p-value for trend p-value for trend 
n=1029 n=1028 n=1029 n=1028 (age adjusted) (age & Bmi adjusted)
Socio-demographic/Lifestyle variables
Age (years) 69.0 ± 5.5 68.8 ± 5.5 68.3 ± 5.5 68.7 ± 5.5 0.19a 0.07b
obesity (BMi ≥ 30 kg/m2) (%) 2.7 9.1 16.4 42.0 <0.001 n/a
current smokers (%) 16.4 12.8 11.4 10.2 <0.001 0.12
Heavy drinkers (%) 3.0 3.2 2.8 3.3 0.77 0.52
Physically inactive (%) 13.4 10.8 9.1 12.6 0.28 <0.001
Manual workers (%) 51.6 49.4 51.7 52.2 0.37 <0.001
Dietary variables 
energy intake (kcal) 2140.0 ± 523.6 2108.4 ± 514.4 2107.6 ± 529.7 2097.5 ± 552.2 0.24 0.20
carbohydrates (% kcal) 52.9 ± 6.9 52.7 ± 7.0 52.7 ± 7.0 51.9 ± 6.8 <0.001 0.13
Protein (% kcal) 15.4 ± 2.4 15.6 ± 2.2 15.7 ± 2.3 16.0 ± 2.3 <0.001 0.02
Fat (% kcal) 30.4 ± 6.2 30.0 ± 6.0 29.9 ± 6.4 30.3 ± 6.1 0.41 0.27
Fiber (g/day) 25.6 ± 8.9 25.8 ± 8.5 26.1 ± 8.6 26.3 ± 9.1 0.08 <0.001
Vitamin c  (mg/day) 80.5 ± 37.5 82.1 ± 35.7 83.3 ± 36.2 86.3 ± 39.3 0.002 0.21
Vitamin e (mg/day) 8.6 ± 5.0 8.4 ± 4.7 8.3 ± 4.7 8.6 ± 4.9 0.05 0.03
iron (mg/day) 14.1 ± 5.3 14.2 ± 5.1 14.1 ± 5.3 14.3 ± 5.1 0.49 0.01
Daily fruit intake (%) 39.5 44.2 41.7 47.3 <0.001 0.001
Daily vegetable intake (%) 30.0 33.9 32.7 35.0 0.02 0.002
Plasma vitamin c (µmol/L) 28.7 ± 24.8 31.2 ± 30.4 31.0 ± 27.9 29.4 ± 22.6 0.59 0.02
Plasma vitamin e (µmol/L) 32.6 ± 11.5 33.8 ± 12.2 33.6 ± 12.2 34.3 ± 11.8 0.002 0.03
Metabolic variables
HoMA-iRc 2.0 (1.2-2.9) 2.2 (1.4-3.0) 2.3 (1.4-3.2) 2.7 (1.6-4.0) <0.001 <0.001
central obesity (%) 14.6 23.1 31.5 49.6 <0.001 n/a
Hypertension (%) 54.4 60.5 58.4 64.3 0.001 0.02
High triglycerides (%) 40.0 44.3 46.5 50.5 <0.001 <0.001
Low HDL (%) 15.5 17.6 22.8 27.7 <0.001 0.47
High glucose (%) 23.7 25.6 23.0 29.2 0.004 0.04
Metabolic syndrome (%) 17.5 23.8 28.6 39.7 <0.001 <0.001
Inflammatory/biological markers
cRP (mg/L)c 1.8 (0.8-3.8) 1.8 (0.8-3.6) 1.7 (0.8-3.3) 1.7 (0.9-3.3) 0.77 <0.001
t-PA (ng/mL) 11.2 ± 4.7 11.1 ± 4.4 10.7 ± 4.3 11.5 ± 4.4 0.01 <0.001
D-dimer (ng/mL)c 85.1 (49.0-133.0) 83.1 (49.0-123.0) 83.6 (47.0-133.5) 83.9 (50.0-127.0) 0.66 0.71
vWF (iu/dL) 144.6 ± 48.2 140.0 ± 45.7 136.6 ± 43.2 138.6 ± 47.1 0.230 <0.001
Fibrinogen (g/L) 3.4 ± 0.8 3.3 ± 0.8 3.2 ± 0.7 3.2 ± 0.7 <0.001 <0.001
iL-6 (pg/mL)c 2.4 (1.6-3.5) 2.4 (1.6-3.4) 2.4 (1.6-3.4) 2.5 (1.6-3.7) 0.05 <0.001
Homocysteine (µmol/L)c 12.9 (10.2-15.5) 12.5 (10.1-14.7) 12.5 (10.1-14.3) 12.8 (10.4-14.8) 0.50 0.11
Values presented as mean ± sD unless otherwise stated. BMi, body mass index; cRP, c-reactive protein; HDL, high density lipoprotein; HoMA-iR, homeostasis model assessment of
insulin resistance; iL-6, interleukin 6; FFMi, fat-free mass index; t-PA, tissue plasminogen activator; vWF, von Willebrand factor. a. unadjusted; b. Adjusted for BMi only; c. Log-
transformed values-geometric mean (interquartile range) presented. 
obesity, high triglycerides, t-PA and the metabolic syndrome
were significantly associated with low FFMi.   
discussion
We explored associations between clinically available and
easily measureable markers of low muscle mass and a range of
lifestyle, dietary and cardiovascular risk factors in older men.
Based on consistent associations with low MAMc and FFMi,
physical inactivity, low percent energy from carbohydrates,
insulin resistance, inflammatory markers (cRP, fibrinogen) and
endothelial dysfunction (vWF) are associated with low muscle
mass, independent of age, obesity, lifestyle and morbidity
variables. 
Physical inactivity was the strongest lifestyle factor
associated with low MAMc and FFMi, consistent with
previous literature (1, 8, 30). this highlights the need for
interventions to increase activity in older adults. current
smoking was not significantly associated with low muscle
mass. this conflicts with earlier studies (1, 30) which may not
have fully adjusted for confounding variables, as in our study
the effect of smoking on muscle mass disappeared after BMi
adjustment. As found previously, heavy alcohol intake was not
a risk factor for low muscle mass (1, 30). 
A high percentage energy intake from carbohydrates was
associated with decreased odds of low MAMc and FFMi. to
our knowledge, this is the first suggestion that high percentage
energy intake of this macronutrient may be protective against
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table 3
Multiple Logistic Regression Analysis of Factors Associated with Low MAMc and FFMi  
Low mamc (or, 95% ci) Low ffmi (or, 95% ci)
model 1 model 2 model 3 model 3
Socio-demographic/Lifestyle variables 
current smokers 1.87 (1.54-2.28)** 1.12 (0.87-1.44) 1.01 (0.78-1.32) 0.94 (0.73-1.22)
Heavy drinkers 1.55 (1.04-2.30)* 1.52 (0.93-2.49) 1.54 (0.92-2.56) 0.80 (0.47-1.36)
Physically inactive 1.43 (1.15-1.76)** 1.97 (1.50-2.59)** 1.69 (1.26-2.27)** 1.43 (1.07-1.90)*
Manual workers 1.14 (0.99-1.31) 1.31 (1.10-1.56)** 1.31 (1.09-1.57)** 1.04 (0.87-1.24)
Dietary variables  
energy intakea 0.99 (0.80-1.22) 0.74 (0.57-0.95)* 0.73 (0.56-0.95)* 1.14 (0.89-1.46)
carbohydrates (% kcal)ab 1.17 (0.95-1.43) 0.72 (0.56-0.94)* 0.73 (0.55-0.96)* 0.76 (0.58-0.99)*
Protein (% kcal)ab 0.78 (0.62-0.96)* 1.21 (0.93-1.59) 1.16 (0.88-1.54) 0.89 (0.68-1.16)
Fat (% kcal)ab 1.18 (0.95-1.46) 1.33 (1.03-1.72)* 1.31 (1.00-1.71)* 1.24 (0.94-1.60)
Fiberab 0.81 (0.65-1.00) 0.93 (0.70-1.22) 0.97 (0.73-1.30) 0.85 (0.64-1.12)
Vitamin cab 0.65 (0.53-0.80)** 0.94 (0.73-1.22) 0.92 (0.70-1.21) 0.98 (0.76-1.28)
Vitamin eab 0.86 (0.69-1.05) 0.95 (0.73-1.25) 0.91 (0.69-1.21) 1.05 (0.80-1.37)
ironab 0.84 (0.65-1.08) 1.03 (0.75-1.42) 1.01 (0.72-1.41) 0.77 (0.56-1.06)
Daily fruit intakeb 0.85 (0.73-0.99)* 1.01 (0.84-1.21) 0.98 (0.81-1.18) 0.89 (0.75-1.07)
Daily vegetable intakeb 0.86 (0.74-1.01) 0.94 (0.78-1.13) 0.94 (0.78-1.14) 0.83 (0.69-1.00)
Plasma vitamin ca 0.84 (0.69-1.04) 0.77 (0.60-1.00)* 0.82 (0.63-1.07) 0.71 (0.55-0.92)*
Plasma vitamin ea 0.71 (0.57-0.88)** 0.87 (0.67-1.13) 0.88 (0.67-1.15) 0.93 (0.72-1.20)
Metabolic variables 
HoMA-iRa 0.37 (0.30-0.46)** 1.64 (1.25-2.17)** 1.60 (1.19-2.17)** 2.22 (1.65-2.98)**
central obesity 0.18 (0.14-0.22)** 1.07 (0.79-1.44) 0.95 (0.70-1.30) 2.01 (1.52-2.67)**
Hypertension 0.72 (0.63-0.84)** 0.96 (0.81-1.15) 0.94 (0.78-1.12) 1.00 (0.84-1.19)
High triglycerides 0.54 (0.47-0.63)‡ 0.93 (0.77-1.11) 0.86 (0.71-1.04) 1.32 (1.10-1.59)**
Low HDL 0.62 (0.51-0.75)** 1.02 (0.81-1.30) 1.00 (0.78-1.28) 0.98 (0.77-1.24)
High glucose 0.96 (0.81-1.13) 1.37 (1.11-1.68)** 1.34 (1.07-1.69)* 1.20 (0.96-1.49)
Metabolic syndrome 0.34 (0.28-0.42)‡ 0.99 (0.77-1.27) 0.89 (0.69-1.16) 1.30 (1.02-1.66)*
Inflammatory/biological markers 
cRPa 0.89 (0.73-1.10) 1.66 (1.28-2.15)** 1.44 (1.09-1.89)* 1.94 (1.48-2.54)**
t-PAa 0.46 (0.40-0.61)** 1.11 (0.85-1.45) 1.01 (0.76-1.33) 2.33 (1.78-3.04)**
D-dimera 1.15 (0.93-1.43) 1.14 (0.88-1.48) 1.03 (0.79-1.36) 0.91 (0.70-1.19)
vWFa 1.49 (1.21-1.83)** 1.74 (1.36-2.23)** 1.67 (1.29-2.17)** 1.57 (1.22-2.02)**
Fibrinogena 1.52 (1.24-1.87)** 1.63 (1.26-2.11)** 1.48 (1.13-1.95)** 1.52 (1.17-1.96)**
iL-6a 1.10 (0.90-1.36) 1.33 (1.02-1.73)* 1.23 (0.94-1.63) 1.13 (0.86-1.47)
Homocysteinea 1.23 (1.00-1.51) 1.22 (0.95-1.58) 1.20 (0.92-1.57) 1.09 (0.84-1.41)
Low MAMc = lowest quartile of MAMc (≤ 24.95 cm). Low FFMi = lowest quartile of FFMi (≤15.96 kg/m2). Model 1: adjusted for age; Model 2: adjusted for model 1 + BMi, smoking,
physical activity, alcohol, social class; Model 3: adjusted for model 2 + morbidity (cVD, diabetes, cancer, FeV1, poor/fair health). cRP, c-reactive protein; HDL, high density
lipoprotein; HoMA-iR, homeostasis model assessment of insulin resistance; iL-6, interleukin 6; FFMi, fat free mass index; MAMc, midarm muscle circumference; t-PA, tissue
plasminogen activator; vWF, von Willebrand factor; * p<0.05 ** p<0.01; a. Highest vs. lowest quartile; b.Additionally adjusted for energy intake in all models. 
low muscle mass. our findings are in keeping with the World
Health organization dietary recommendations of a low-fat
high-carbohydrate diet, with 55-75% energy from
carbohydrates (31). consistent with literature suggesting energy
intake is important for the prevention of low muscle mass (10)
we found an association between low energy intake and low
MAMc, emphasising the need for an adequate calorie intake in
older adults. no other dietary variables were significantly
associated with low MAMc and FFMi, contrasting with
previous studies showing independent relationships with
protein, iron and antioxidants (9, 10). 
insulin resistance and blood glucose were the only metabolic
risk factors associated with low MAMc and FFMi. this
supports research showing insulin resistance is inversely
associated with low muscle mass, independent of obesity (32),
and may explain why diabetics are prone to sarcopenia (33).
this finding has important implications for management of
insulin resistance and diabetes for sarcopenia prevention. 
two inflammatory markers (cRP and fibrinogen) were
significantly associated with low MAMc and FFMi. this is
consistent with other studies (34, 35) and a review suggesting
sarcopenia is a low-level inflammatory state driven by
cytokines and oxidative stress (11). these findings highlight the
importance of reducing inflammation in older adults,
potentially through lifestyle modifications such as increasing
physical activity or an anti-inflammatory diet, especially since
inflammatory markers increase with age (22, 36). Associations
between vWF and t-PA with low muscle mass were novel and
consistent with a review suggesting that endothelial dysfunction
may contribute to sarcopenia development (12). thus
sarcopenia may be a pathway by which endothelial dysfunction
may contribute to poorer functional status reported in other
studies (37). the lack of association between D-dimer, iL-6 and
homocysteine and low MAMc/FFMi supports evidence
showing no consistent association between high iL-6 and
sarcopenia (38), but is contrary to research showing
associations between these three biomarkers and sarcopenia
(34, 35).  
the study’s major strength is the use of two clinically
available and easily measurable markers of muscle mass to
identify lifestyle, dietary and cardiovascular risk factors.
Although more precise muscle mass measures (e.g.
computerized tomography, magnetic resonance imaging, dual-
energy X-ray absorptiometry) were unavailable here, such
expensive measures are rarely available in primary care settings
and MAMc/FFMi measures represent practical alternatives.
using indirect measurements of muscle mass may have
attenuated observed associations with risk factors. the lowest
quartile of MAMc cut-point (24.95 cm) was comparable to
another population-based study, which used a cut-point for the
lowest tertile of 21.1 cm for slightly older men, aged >80 years
(39). similarly, the lowest quartile of FFMi cut-point (15.96
kg/m2) was comparable to a study in men and women, where
the lowest quartile cut-point was 14.6 kg/m2 (40). the
european and international Working Groups on sarcopenia
have recommended using both low muscle mass and low
muscle function (strength or performance) to diagnose
sarcopenia (4, 7). However, muscle function measures were
unavailable in this study and therefore findings are applicable
to low muscle mass, but not necessarily to low muscle strength
or performance. 
this study has some limitations. Firstly, it was cross-
sectional so causality cannot be established and findings should
therefore be interpreted with caution. the assessment of
sarcopenia was based on low muscle mass, measured at one
time point, since data on loss of muscle mass over time were
unavailable. some differences were observed in the
associations of risk factors with MAMc and FFMi. this could
be explained by the greater inaccuracy of BiA in assessment of
FFMi in older people, predominantly due to fat-free mass
hydration variability (41, 42). non-participation bias is
possible, as men too unwell to attend the physical examination
would have been excluded, potentially eliminating men with
extremely low muscle mass and underestimating observed
associations. this may explain why some variables previously
associated with low muscle mass, e.g. protein intake, were not
related in this study.  However, the response rate was high and
BMi did not differ between respondents and non-respondents
(14), suggesting the extent of this bias is limited. since this
study was in older men, predominantly of white european
ethnic origin, generalisation of findings to women and non-
white ethnic groups should be cautious. several exposure
variables were based on self-reports, so misclassification was
possible. However, previous food frequency questionnaire
validation reduces the risk of bias for dietary variables (19-21).
Physical inactivity, low percent energy from carbohydrates,
high levels of insulin resistance, inflammation (cRP,
fibrinogen) and endothelial dysfunction (vWF) are associated
with low muscle mass, as measured by MAMc and FFMi, in
older men. our findings suggest that increasing physical
activity, consuming a diet with a high proportion of energy
from carbohydrates, and taking steps to prevent insulin
resistance and reduce inflammation and endothelial dysfunction
may help to reduce the risk of low muscle mass in older men.
However, further longitudinal studies are needed to confirm the
causality of these associations. 
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